Biohaven Pharmaceutical Holding Co Ltd.

DRIEHAUS CAPITAL MANAGEMENT LLC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

50,830

Value ($000)

7,406

Weight

0.1%

2021 Q3 - 2022 Q2 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	7,406	0.1%	50,830	6/30/2022
2021 Q4	2/14/2022	24,823	0.3%	180,126	12/31/2021
2021 Q3	11/15/2021	17,912	0.2%	128,946	9/30/2021